Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status

Mette Hjortkjær, Hanne Kanstrup, Anders Jakobsen, Karina Dahl Steffensen

Research output: Contribution to journalJournal articleResearchpeer-review

268 Downloads (Pure)
Original languageEnglish
JournalCancer Treatment and Research Communications
Pages (from-to)7-12
Publication statusPublished - 1. Jan 2018

Bibliographical note

2018;14:7-12. doi: 10.1016/j.ctarc.2017.09.001. Epub 2017 Sep 27.

Cite this